KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
125 hedge funds and large institutions have $313M invested in Keryx Biopharmaceuticals Inc in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
42% less call options, than puts
Call options by funds: $2.65M | Put options by funds: $4.58M
Holders
125
Holding in Top 10
–
Calls
$2.65M
Puts
$4.58M
Top Buyers
| 1 | +$3.85M | |
| 2 | +$689K | |
| 3 | +$632K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$529K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$404K |
Top Sellers
| 1 | -$2.75M | |
| 2 | -$1.46M | |
| 3 | -$1.43M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$823K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$749K |